Literature DB >> 6572936

Prostaglandin D2, a cerebral sleep-inducing substance in rats.

R Ueno, K Honda, S Inoué, O Hayaishi.   

Abstract

We continuously monitored the circadian sleep patterns of unrestrained rats for more than 96 hr and infused various prostaglandins into their third ventricles for 10 hr to study the effects on inducing sleep. Prostaglandin D2 at 6 fmol/min had no effect on either slow wave sleep or paradoxical sleep. However, prostaglandin D2 at as little as 60 fmol/min caused a significant amount of excess slow wave sleep as compared with the control level during saline infusion. Paradoxical sleep was induced by prostaglandin D2 at doses greater than 600 fmol/min. Prostaglandin D2 (600 fmol/min) increased slow wave sleep by 33% and paradoxical sleep by 56%. Although prostaglandin F2 alpha (600 fmol/min) increased the amount of slow wave sleep, its activity was less than that of the same amount of prostaglandin D2. Prostaglandin E2 (600 fmol/min) had no effect on increasing the amounts of both slow wave sleep and paradoxical sleep. During the infusion of prostaglandin D2, rats were easily aroused by clap sound stimulation and their sleeping and waking postures remained normal. Further, their sleep was episodic, as observed in the physiological sleep of rats.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6572936      PMCID: PMC393678          DOI: 10.1073/pnas.80.6.1735

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Extraction of sleep-promoting factor S from cerebrospinal fluid and from brains of sleep-deprived animals.

Authors:  J R Pappenheimer; G Koski; V Fencl; M L Karnovsky; J Krueger
Journal:  J Neurophysiol       Date:  1975-11       Impact factor: 2.714

2.  Hypothalamic Temperature in the Cat during Feeding and Sleep.

Authors:  T Adams
Journal:  Science       Date:  1963-02-15       Impact factor: 47.728

3.  Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution.

Authors:  S Narumiya; T Ogorochi; K Nakao; O Hayaishi
Journal:  Life Sci       Date:  1982-11-08       Impact factor: 5.037

4.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

5.  Metabolism and thermoregulation during stages of sleep in humans exposed to heat and cold.

Authors:  E H Haskell; J W Palca; J M Walker; R J Berger; H C Heller
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-10

6.  Internal temperature variations during the sleep-wake cycle in the rat.

Authors:  B Roussel; A Dittmar; G Chouvet
Journal:  Waking Sleeping       Date:  1980 Jan-Mar

7.  Prostaglandin D2, a neuromodulator.

Authors:  T Shimizu; N Mizuno; T Amano; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

8.  An NADP-linked prostaglandin D dehydrogenase in swine brain.

Authors:  K Watanabe; T Shimizu; S Iguchi; H Wakatsuka; M Hayashi; O Hayaishi
Journal:  J Biol Chem       Date:  1980-03-10       Impact factor: 5.157

9.  Sleep-promoting effects of muramyl peptides.

Authors:  J M Krueger; J R Pappenheimer; M L Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  Characterization of a delta-electroencephalogram (-sleep)-inducing peptide.

Authors:  G A Schoenenberger; M Monnier
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more
  37 in total

1.  Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep.

Authors:  E Pinzar; Y Kanaoka; T Inui; N Eguchi; Y Urade; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Brain mast cells link the immune system to anxiety-like behavior.

Authors:  Katherine M Nautiyal; Ana C Ribeiro; Donald W Pfaff; Rae Silver
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-11       Impact factor: 11.205

Review 3.  Sleep neurobiology from a clinical perspective.

Authors:  Rodrigo A España; Thomas E Scammell
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

4.  Augmented generation of protein fragments during wakefulness as the molecular cause of sleep: a hypothesis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2012-11       Impact factor: 6.725

Review 5.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

6.  Role of the L-PGDS-PGD2-DP1 receptor axis in sleep regulation and neurologic outcomes.

Authors:  Abdullah Shafique Ahmad; Haneen Ottallah; Carolina B Maciel; Michael Strickland; Sylvain Doré
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

7.  In Memoriam: Osamu Hayaishi (1920 – 2015).

Authors:  Shuh Narumiya; Takao Shimizu; Shozo Yamamoto
Journal:  J Lipid Res       Date:  2016-04       Impact factor: 5.922

8.  The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients.

Authors:  N Iwamoto; K Kobayashi; K Kosaka
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

9.  Changes of the activities of enzymes involved in prostaglandin synthesis in rat skin during development and aging.

Authors:  K Ikai; M Ujihara; Y Urade
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

10.  The effect of diclofenac and ketoprofen on halothane MAC in rabbit.

Authors:  M G Rorarius; G A Baer; T Metsä-Ketelä
Journal:  Agents Actions       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.